Articles with the keyword: 
Potential Therapeutic Strategy for Type I Diabetes
jerry submitted, created time 3 months 3 days (diabetes.diabetesjournals.org)
Mesenchymal stem cells (MSCs) are pluripotent stromal cells that have the potential to give rise to cells of diverse lineages. Interestingly, MSCs can be found in virtually all postnatal tissues. The main criteria currently used to characterize and identify these cells are the capacity for self-renewal and differentiation into tissues of mesodermal origin, combined with a lack in expression of certain hematopoietic molecules. Because of their developmental plasticity, the notion of MSC-based therapeutic intervention has become an emerging strategy for the replacement of injured tissues 


IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions
davidd submitted, created time 6 months 2 weeks (www.pnas.org)
EndoS from Streptococcus pyogenes efficiently hydrolyzes the functionally important and conserved N-linked glycan of IgG in human blood. Repeated i.v. administration of EndoS in rabbits completely hydrolyzes the glycans of the whole IgG pool, despite the generation of anti-EndoS antibodies. EndoS administration had no apparent effects on the health of the animals 
\ 1
\